NVO Jan 2025 110.000 call
| Previous close | 27.40 |
| Open | 27.80 |
| Bid | 0.00 |
| Ask | 0.00 |
| Strike | 110.00 |
| Expiry date | 2025-01-17 |
| Day's range | 27.40 - 28.20 |
| Contract range | N/A |
| Volume | |
| Open interest | 755 |
- Yahoo Finance Video
Apple, Novo Nordisk earnings, jobless claims: What to watch
A number of companies release their quarterly earning reports on Thursday, including Apple (AAPL), Novo Nordisk (NVO), Shell (SHEL), ConocoPhillips (COP), Cigna (CI), Coinbase (COIN), Moderna (MRNA), DraftKings (DKNG), Kellanova (K), United States Steel (X), and more. On the economic front, jobless claims for the week ending on April 27 will be released. Economists expect claims to rise to 212,000 from 207,000 the prior week. For more expert insight and the latest market action, click here to watch this full episode of Market Domination Overtime. This post was written by Nicholas Jacobino
- Reuters
UPDATE 1-Novo Nordisk: Wegovy, Ozempic prices in US fell in Q1
Novo Nordisk has seen the price of its hugely popular weight-loss drug Wegovy and diabetes drug Ozempic fall in the United States as volumes and competition have increased, a senior executive said on Thursday. Wegovy prices in the United States were "slightly down" in the first quarter and Novo expects further decreases through the rest of 2024, Chief Financial Officer Karsten Munk Knudsen said on a call with media.
Investor's Business DailyNovo Nordisk Dips As Q1 Wegovy Sales Double, But Miss Target
Novo Nordisk stock came under mild selling pressure early Thursday, after the company reported Q1 results and lifted guidance.
